Radiomics predict postoperative survival of patients with primary liver cancer with different pathological types

BACKGROUND: Radiomics can be used to determine the prognosis of liver cancer, but it might vary among cancer types. This study aimed to explore the clinicopathological features, radiomics, and survival of patients with hepatocellular carcinoma (HCC), mass-type cholangiocarcinoma (MCC), and combined...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jiahui, Wang, Xiaoli, Zhang, Lixia, Yao, Linpeng, Xue, Xing, Zhang, Siying, Li, Xin, Chen, Yuanjun, Pang, Peipei, Sun, Dongdong, Xu, Juan, Shi, Yanjun, Chen, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396247/
https://www.ncbi.nlm.nih.gov/pubmed/32793665
http://dx.doi.org/10.21037/atm-19-4668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396247/
https://www.ncbi.nlm.nih.gov/pubmed/32793665
http://dx.doi.org/10.21037/atm-19-4668

Ejemplares similares